Jane Wolstenholme

• Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study

  Burns RM. et al, (2017), Global and Regional Health Technology Assessment

• Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy.

  Baker K. et al, (2017), International journal of medical informatics, 103, 32 - 41

• Effect of oral dexamethasone without immediate antibiotics vs placebo on acute sore throat in adults: a Randomized Clinical Trial

  Hayward GN. et al, (2017), Journal of the American Medical Association

• Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.

  Watson E. et al, (2016), BJU Int, 117, E10 - E19

• Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions

  Briggs ADM. et al, (2016), Population Health Metrics, 14, 17 - 17

• Non-contact infrared thermometers for measuring temperature in children: primary care diagnostic technology update.

  Wang K. et al, (2014), Br J Gen Pract, 64, e681 - e683

• Oral corticosteroid use for clinical and cost-effective symptom relief of sore throat: study protocol for a randomized controlled trial.

  Cook J. et al, (2014), Trials, 15

• Economic evaluations in bipolar disorder: a systematic review and critical appraisal.

  Abdul Pari AA. et al, (2014), Bipolar Disord, 16, 557 - 582

• Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies.

  Leal J. et al, (2014), Int J Urol, 21, 786 - 792

• PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial.

  Watson E. et al, (2014), BMJ Open, 4

• Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial

  Hill NR. et al, (2014), Trials, 160

• The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK.

  Hill NR. et al, (2013), BMJ Open, 3

• Point-of-care testing for coeliac disease: primary care diagnostic technology update.

  Khangura J. et al, (2013), Br J Gen Pract, 63, e426 - e428

• Placebo use in the United kingdom: results from a national survey of primary care practitioners.

  Howick J. et al, (2013), PLoS One, 8

• The D-Dimer test in combination with a decision rule for ruling out deep vein thrombosis in primary care: diagnostic technology update.

  Plüddemann A. et al, (2012), Br J Gen Pract, 62, e393 - e395

• Point-of-care testing for the analysis of lipid panels: primary care diagnostic technology update.

  Plüddemann A. et al, (2012), Br J Gen Pract, 62, e224 - e226

• Point of care testing INR coagulometers for self-management of oral anticoagulation; Primary Care Diagnostic Technology Update

  Thompson MJ. et al, (2012), British Journal of General Practice

• Spirometry in primary care for case finding and management of chronic obstructive pulmonary disease primary care diagnostic technology update.

  Parkes G. et al, (2011), Br J Gen Pract, 61, 698 - 699

• Point-of-care blood test for ketones in patients with diabetes: primary care diagnostic technology update.

  Plüddemann A. et al, (2011), Br J Gen Pract, 61, 530 - 531

• Dermoscopy for the diagnosis of melanoma: primary care diagnostic technology update.

  Plüddemann A. et al, (2011), Br J Gen Pract, 61, 416 - 417

• Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin.

  Plüddemann A. et al, (2011), Br J Gen Pract, 61, 139 - 140

• Applied Methods of Cost-effectiveness Analysis in Healthcare

  Clarke PM. et al, (2010)

• Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.

  Rivero-Arias O. et al, (2010), Med Decis Making, 30, 341 - 354

• Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom.

  Rivero-Arias O. et al, (2010), Cost Eff Resour Alloc, 8

• The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial.

  Rivero-Arias O. et al, (2009), J Neurol, 256, 364 - 373

• From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.

  Legood R. et al, (2009), Health Policy, 89, 193 - 200

• A Rapid Review of Economic Literature Related to The Promotion of Physical Activity, Play and Sport for Pre-school and School Age Children in Family, Pre-school, School and Community Settings

  Buchanan JR. et al, (2009), National Institute of Health and Clinical Excellence

• Treatment pathways, resource use, and costs of endovascular coiling versus surgical clipping after aSAH.

  Wolstenholme J. et al, (2008), Stroke, 39, 111 - 119

• Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

  Whynes DK. et al, (2005), Int J Health Care Finance Econ, 5, 369 - 386

• Eliciting relative preferences for two methods of colorectal cancer screening.

  Frew EJ. et al, (2005), Eur J Cancer Care (Engl), 14, 124 - 131

• Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats.

  Frew EJ. et al, (2004), Health Policy, 68, 289 - 298

• Evidence of range bias in contingent valuation payment scales.

  Whynes DK. et al, (2004), Health Econ, 13, 183 - 190

• A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.

  Whynes DK. et al, (2003), J Health Econ, 22, 555 - 574

• Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats.

  Frew EJ. et al, (2003), Med Decis Making, 23, 150 - 159

• Willingness-to-pay for colorectal cancer screening.

  Frew E. et al, (2001), Eur J Cancer, 37, 1746 - 1751

• Transcranial Doppler-directed Dextran-40 therapy is a cost-effective method of preventing carotid thrombosis after carotid endarterectomy.

  Hayes PD. et al, (2000), Eur J Vasc Endovasc Surg, 19, 56 - 61

Recent Publications

• Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study

  Burns RM. et al, (2017), Global and Regional Health Technology Assessment

• Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy.

  Baker K. et al, (2017), International journal of medical informatics, 103, 32 - 41

• Effect of oral dexamethasone without immediate antibiotics vs placebo on acute sore throat in adults: a Randomized Clinical Trial

  Hayward GN. et al, (2017), Journal of the American Medical Association

• Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.

  Watson E. et al, (2016), BJU Int, 117, E10 - E19

• Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions

  Briggs ADM. et al, (2016), Population Health Metrics, 14, 17 - 17